Abstract

The Transmission Reduction Intervention Project (TRIP) was a network-based, enhanced contact tracing approach, targeting recently HIV-infected people who inject drugs (PWID) in Athens, Greece (2013–2015). This analysis examines behavioral changes of participants in TRIP and their determinants between baseline and follow-up visits to the program. All participants of TRIP were tested for HIV and interviewed using a questionnaire with items on drug injection-related and sexual behaviors. Multivariable logistic regression models were used to examine potential relationships between participants’ behaviors and sociodemographic or other characteristics. The analysis included 292 participants. At follow-up, the percentage of participants who injected drugs decreased [92.5%, n = 270 versus 72.3%, n = 211 (p < 0.001)], and more participants adopted safer behaviors. Employment, age, and gender were significantly associated with some behavioral changes. For instance, unemployed participants were half as likely as the employed to stop drug injection [adjusted odds ratio (aOR): 0.475, 95% confidence interval (CI): 0.228, 0.988]. Increasing age was associated with lower probability of sharing syringes at follow-up (aOR: 0.936, 95%CI: 0.887, 0.988). Finally, females were less likely than males to improve their behavior related to sharing cookers, filters, or rinse water (aOR: 0.273, 95% CI: 0.100, 0.745). In conclusion, adoption of safer behaviors was observed following TRIP implementation. Future prevention programs should focus on younger PWID and especially females. Social efforts to support employment of PWID are also important.

Highlights

  • The sociodemographic characteristics of the participants who were followed-up were significantly different compared to those who were lost to follow-up with regards to homelessness status, nationality

  • Participant group

  • This study examined behavioral changes observed among people who inject drugs and participated in a network-based intervention in Athens, Greece

Read more

Summary

Introduction

The global health burden from human immunodeficiency virus (HIV) remains high: at the end of 2019, 38 million [31.6–44.5 million] people were living with HIV (PLHIV), and 1.7 million individuals became infected [1]. AIDS and experience opportunistic infections and cancers. PLHIV, who are on combination antiretroviral treatment (ART), have a similar life expectancy to individuals without HIV and they are at increased risk of developing non-AIDS comorbidities such as cardiovascular disease [2]. As an effective vaccine for eradication of HIV has not yet been developed [3], preventive measures for the containment of the virus remain to date the first public health priority

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call